摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pyridine-2-carboxylic acid (4,4-diphenylpropyl)amide

中文名称
——
中文别名
——
英文名称
pyridine-2-carboxylic acid (4,4-diphenylpropyl)amide
英文别名
Pyridine-2-carboxylic acid (3,3-diphenyl-propyl)-amide;Pyridine-2-carboxylic Acid(4,4-Diphenyl-propyl)-amide;N-(3,3-diphenylpropyl)pyridine-2-carboxamide
pyridine-2-carboxylic acid (4,4-diphenylpropyl)amide化学式
CAS
——
化学式
C21H20N2O
mdl
——
分子量
316.403
InChiKey
JLODJWGIRDCEPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    42
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    铜催化配位基团辅助的炔烃 1,2-二官能化三氟甲基酰胺化反应
    摘要:
    炔烃的自由基 1,2-双官能化反应已发展成为制备多取代亚烷基的通用方法。然而,尽管生成的烯胺在天然分子、生物活性和药物化合物中普遍存在,但仍缺乏进行碳胺化的强有力的催化策略。在此,我们表明,明智地安装在胺上的二齿配位基团可以作为实现炔烃自由基三氟甲基酰胺化的有效工具。该策略表现出广泛的底物范围和良好的官能团兼容性,适合天然化合物和生物学相关基序的后期功能化,从而可以直接合成大型 CF 3文库含有烯酰胺的高价值药效团,只需一步即可从易于获得的酰胺、朗格卢瓦试剂和炔烃中获得。目前的方法还可以成功扩展到炔烃的二氟甲基酰胺化。此外,还进行了各种机理实验,如竞争实验、H/D同位素交换实验、自由基陷阱实验、哈米特研究和动力学研究,以更好地理解反应机理。
    DOI:
    10.1021/acscatal.3c02662
  • 作为产物:
    描述:
    2-吡啶甲酸3,3-二苯基丙胺1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以11%的产率得到pyridine-2-carboxylic acid (4,4-diphenylpropyl)amide
    参考文献:
    名称:
    Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
    摘要:
    Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of all effort to identify inhibitors of sEH with high and sustained plasma exposure, we recently performed a high throughput screen of our compound collection, The screen identified N-(3,3-diphenylpropyl)-nicotinamide as a potent inhibitor of sEH. Further profiling of this lead revealed short metabolic half-lives in microsomes and rapid clearance in the rat. Consistent with these observations, the determination of the in vitro metabolic profile of N-(3,3-diphenyl-propyl)-nicotinamide in rat liver microsomes revealed extensive oxidative metabolism and a propensity for metabolite switching. Lead optimization, guided by the analysis of the solid-state costructure of N-(3,3-diphenyl-propyl)-nicotinamide bound to human sEH, led to the identification of a class of potent and selective inhibitors. An inhibitor from this class displayed an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration.
    DOI:
    10.1021/jm9005302
点击查看最新优质反应信息

文献信息

  • Coordinating activation strategy enables 1,2-alkylamidation of alkynes
    作者:Jing Ren、Junhua Xu、Xiangxiang Kong、Jinlong Li、Kaizhi Li
    DOI:10.1039/d3sc03786j
    日期:——

    The radical 1,2-difunctional alkylamidation of alkynes has been developed with the help of a bidentate coordinating group for the synthesis of β-alkylated enamides.

    在双齿配位基团的帮助下,开发了炔烃的 1,2-二官能团烷基酰胺化作用,用于合成 β-烷基化烯酰胺。
  • Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
    作者:Anne B. Eldrup、Fariba Soleymanzadeh、Steven J. Taylor、Ingo Muegge、Neil A. Farrow、David Joseph、Keith McKellop、Chuk C. Man、Alison Kukulka、Stéphane De Lombaert
    DOI:10.1021/jm9005302
    日期:2009.10.8
    Inhibition of soluble epoxide hydrolase (sEH) is hypothesized to lead to an increase in circulating levels of epoxyeicosatrienoic acids, resulting in the potentiation of their in vivo pharmacological properties. As part of all effort to identify inhibitors of sEH with high and sustained plasma exposure, we recently performed a high throughput screen of our compound collection, The screen identified N-(3,3-diphenylpropyl)-nicotinamide as a potent inhibitor of sEH. Further profiling of this lead revealed short metabolic half-lives in microsomes and rapid clearance in the rat. Consistent with these observations, the determination of the in vitro metabolic profile of N-(3,3-diphenyl-propyl)-nicotinamide in rat liver microsomes revealed extensive oxidative metabolism and a propensity for metabolite switching. Lead optimization, guided by the analysis of the solid-state costructure of N-(3,3-diphenyl-propyl)-nicotinamide bound to human sEH, led to the identification of a class of potent and selective inhibitors. An inhibitor from this class displayed an attractive in vitro metabolic profile and high and sustained plasma exposure in the rat after oral administration.
  • Copper-Catalyzed 1,2-Difunctionalization Trifluoromethylamidation of Alkynes Assisted by a Coordinating Group
    作者:Jing Ren、Kaiyun Liu、Ning Wang、Xiangxiang Kong、Jinlong Li、Kaizhi Li
    DOI:10.1021/acscatal.3c02662
    日期:2023.8.18
    amenable for late-stage functionalization of natural compounds and biologically relevant motifs, allowing a straightforward synthesis of a large library of CF3-containing enamides, the high-value pharmacophores, in a single step from readily accessible amides, Langlois’ reagent, and alkynes. The current methodology can also be successfully extended to difluoromethylamidation of alkynes. Additionally
    炔烃的自由基 1,2-双官能化反应已发展成为制备多取代亚烷基的通用方法。然而,尽管生成的烯胺在天然分子、生物活性和药物化合物中普遍存在,但仍缺乏进行碳胺化的强有力的催化策略。在此,我们表明,明智地安装在胺上的二齿配位基团可以作为实现炔烃自由基三氟甲基酰胺化的有效工具。该策略表现出广泛的底物范围和良好的官能团兼容性,适合天然化合物和生物学相关基序的后期功能化,从而可以直接合成大型 CF 3文库含有烯酰胺的高价值药效团,只需一步即可从易于获得的酰胺、朗格卢瓦试剂和炔烃中获得。目前的方法还可以成功扩展到炔烃的二氟甲基酰胺化。此外,还进行了各种机理实验,如竞争实验、H/D同位素交换实验、自由基陷阱实验、哈米特研究和动力学研究,以更好地理解反应机理。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐